We recently published a list of 20 Stocks Insiders Were Buying In Q1 2025. In this article, we are going to take a look at where iBio, Inc. Common Stock (NASDAQ:IBIO) stands against other stocks insiders were buying in Q1 2025.
About 30 minutes before the market closed Monday, the broader market index was up 0.3%, while the blue-chip companies gained 0.9%. Meanwhile, the Nasdaq Composite dropped 0.5%. Some stocks were recovering from Friday losses after inflation data came in higher than expected, coupled with weak consumer sentiment, which heightened concerns about the U.S. economy’s stability, according to Investopedia.
As investors react to daily market changes, ongoing uncertainty continues to affect the market. During such times, insider trading often garners attention, as executive purchases of company stock can signal optimism about the company’s prospects. However, insider sales do not always indicate a lack of confidence—they may be influenced by personal financial reasons or a need for diversification. Executives often follow pre-arranged plans, like 10b5-1, to ensure transparency. While insider trading can offer valuable insights, it should be considered alongside a company’s financial health, market conditions, and industry shifts.
Our Methodology
What are some of the stocks insiders have been buying the most in the first quarter of the year? To find out, we used Insider Monkey’s insider trading stock screener, focusing only on stocks where at least five insiders had purchased shares in January, February, and March. From there, we ranked the 20 stocks with the highest number of insiders purchasing shares.
Our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds, focusing on insider trading and stock picks from hedge fund investor newsletters and conferences. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
With each stock, we note the average price per share of these purchases and the stock’s market capitalization.
A biotechnologist in a lab wearing an apron and safety glasses, working on a biopharmaceutical process.
iBio, Inc. Common Stock (NASDAQ:IBIO)
Market Cap: $40.68 million
Number of insiders buying: 7
iBio is a biotechnology firm that leverages AI and advanced computational biology to develop biopharmaceuticals targeting cardiometabolic diseases, obesity, cancer, and other challenging conditions. The San Diego, California-based company uses proprietary 3D modeling and innovative drug discovery platforms to build a pipeline of novel antibody treatments for unmet medical needs. It is also one of the 12 best biotech penny stocks to invest in.
For the second quarter of fiscal 2025, iBio reported $200,000 in revenue and a net loss of $4.36 million, compared to a net loss of $4.49 million in the same period last year.
Earlier this year, iBio announced a collaboration with AstralBio Inc. to develop an antibody that targets Activin E, a potential treatment for cardiometabolic disorders and obesity, using iBio’s proprietary Machine-Learning Antibody Engine.
In January, seven insiders, including the company’s CFO, acquired approximately $654,995 worth of iBio shares at an average price of $2.72 per share. Year-to-date, the stock gained 59.59%, trading at $3.91 per share. Over the past 12 months, iBio shares rose 16.72%.
Based on the estimates of three analysts, iBio stock is a ‘Strong Buy’ with a price target of $4.87. The average price target suggests a 27.49% upside from the latest price.
Overall, IBIO ranks 18th on our list of stocks insiders were buying in Q1 2025. While we acknowledge the potential of IBIO our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than IBIO but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. This article is originally published at Insider Monkey.
